Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1Breast 1

Conditions

Breast Neoplasms 4Prostatic Neoplasms 3Colorectal Neoplasms 3Neoplasms 2Neoplasm Metastasis 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Colonic Neoplasms 2Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1Testicular Germ Cell Tumor 1Stroke 1Stomach Neoplasms 1Renal Insufficiency 1Prostate Cancer Metastatic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Obesity 1Non-alcoholic Fatty Liver Disease 1Neoplastic Cells, Circulating 1Motor Activity 1Metabolic Syndrome 1Memory Disorders 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Liver Cirrhosis 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1Heart Diseases 1HPV Positive Oropharyngeal Squamous Cell Carcinoma 1

Interventions

Fluorouracil 128Leucovorin 120Oxaliplatin 101Irinotecan 89Bevacizumab 55Cetuximab 44Capecitabine 40Folfox protocol 29Panitumumab 22Colonoscopy 17Chemotherapy, Adjuvant 16Floxuridine 15Early Intervention, Educational 15Erlotinib Hydrochloride 13Surveys and Questionnaires 11IFL protocol 11Counseling 11Celecoxib 11Immunohistochemistry 10Gemcitabine 10Psychiatric Rehabilitation 9Methods 8Magnetic Resonance Spectroscopy 8Gene Expression Profiling 8Exercise 8Dexamethasone 8sargramostim 7Sorafenib 7Radiotherapy 7Nivolumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Colonic Neoplasms × Hematologic Tests × Clear all
NCT03284684 2025-12-01

Periop ctDNA

Centre Hospitalier Universitaire de Nīmes

Completed
30 enrolled
BreastGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Prostatic Neoplasms

NCT06454071 2024-06-12

Immunologic Changes and Recovery-related Factors in Elderly Colon Cancer Patients

Soonchunhyang University Hospital

Phase 2 Completed
75 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡